FIELD: medicine.
SUBSTANCE: method involves introducing Sulodexid as coagulant at a dose determined in correspondence with coagulation constant KK. Its value being equal to 6.67±0.21 min, initial Sulodexid dose is equal to 40 LRU/kg/day. KK value being less than 18 min one day later, the initial Sulodexid dose is increased by 5 LRU/kg/day. The value being greater than 30 min, the dose is reduced by 5 LRU/kg/day. No inflammatory phenomena being observed and burn wound epithelialization signs appearing, Sulodexid therapy is cancelled reducing its dose by 1/3 of the initial one.
EFFECT: stable antithrombotic; reduced risk of hemorrhagic and pyoinflammatory complications; early injured skin epithelialization.
1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING BURN SHOCK DEGREE IN CHILDREN HAVING THERMIC INJURY | 2006 |
|
RU2313791C1 |
| WAY OF TREATMENT OF BURN DISEASE AT CHILDREN WITH SERIOUS THERMAL TRAUMA | 2007 |
|
RU2362591C1 |
| METHOD OF COMBINED TREATMENT OF CHILDREN WITH SEVERE THERMAL INJURY | 2011 |
|
RU2482894C1 |
| DIAGNOSTIC TECHNIQUE FOR COMPLICATED FORMS OF OVERACTIVE BLADDER IN CHILDREN | 2012 |
|
RU2497115C1 |
| METHOD FOR ASSESSING LEVEL OF UNFRACTIONATED HEPARIN INDUCED ANTICOAGULATION IN HAEMODIALYSIS IN PATIENTS WITH ACUTE RENAL INJURY | 2014 |
|
RU2571505C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF HEMOSTASIS SYSTEM DISORDERS IN PATIENTS WITH ACUTE BLOOD LOSS | 2004 |
|
RU2263914C1 |
| METHOD FOR PREDICTING ACUTE PULMONARY LESION SYNDROME DEVELOPMENT CHANCES IN ACUTE HEMORRHAGE PATIENTS | 2004 |
|
RU2273852C2 |
| METHOD FOR TESTING ANTICOAGULANT ACTIVITY OF BLOOD | 2012 |
|
RU2530584C2 |
| METHOD FOR DIFFERENTIATED EVALUATION OF HEMOSTASIS IN PREMATURE NEONATALS | 2002 |
|
RU2216745C2 |
| METHOD FOR PREDICTING IN ACUTE BLOOD LOSS PATIENTS | 2004 |
|
RU2269129C1 |
